A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
NCT02206165
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
456
Enrollment
INDUSTRY
Sponsor class
Conditions
Essential Hypertension
Interventions
DRUG:
Candesartan 8mg
DRUG:
Candesartan 16mg
DRUG:
Amlodipine 5mg
DRUG:
Amlodipine 10mg
Sponsor
Chong Kun Dang Pharmaceutical